Pfizer and OPKO's Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing ...

Medicine

Clinical medicine

Organ systems

Growth hormones

Growth disorders

Growth hormone therapy

Pediatrics

Pfizer

Growth hormone

GHD

Medroxyprogesterone acetate

Turner syndrome

recombinant human growth hormone

GENOTROPIN

I Pfizer Inc.

Opko Health Inc.

Pfizer and OPKO's Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing .... View article details on HISWAI: https://pipelinereview.com/index.php/2022021680358/Proteins-and-Peptides/Pfizer-and-OPKOs-Once-Weekly-NGENLA-somatrogon-Injection-Receives-Marketing-Authorization-in-European-Union-for-Treatment-of-Pediatric-Growth-Hormone-Deficiency.html